IRIS UniCatt

Piermattei, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.865
EU - Europa 3.643
AS - Asia 2.829
SA - Sud America 575
AF - Africa 110
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.768
DE - Germania 1.421
SG - Singapore 1.334
CN - Cina 819
SE - Svezia 624
BR - Brasile 487
UA - Ucraina 390
IT - Italia 340
FR - Francia 174
IN - India 164
IE - Irlanda 156
FI - Finlandia 139
GB - Regno Unito 139
VN - Vietnam 104
ID - Indonesia 103
TR - Turchia 67
RU - Federazione Russa 66
CI - Costa d'Avorio 55
CA - Canada 44
NL - Olanda 41
AR - Argentina 37
BD - Bangladesh 37
MX - Messico 33
IQ - Iraq 32
JP - Giappone 32
BE - Belgio 30
HK - Hong Kong 28
IR - Iran 21
ZA - Sudafrica 20
PL - Polonia 19
CZ - Repubblica Ceca 18
EC - Ecuador 17
AT - Austria 14
ES - Italia 13
LT - Lituania 13
KR - Corea 12
MA - Marocco 10
SA - Arabia Saudita 10
PK - Pakistan 9
CL - Cile 8
CO - Colombia 8
VE - Venezuela 8
AU - Australia 7
AZ - Azerbaigian 7
IL - Israele 7
AE - Emirati Arabi Uniti 6
HU - Ungheria 6
RO - Romania 6
UZ - Uzbekistan 6
EG - Egitto 5
KE - Kenya 5
BG - Bulgaria 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
LU - Lussemburgo 4
NP - Nepal 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
AL - Albania 3
AO - Angola 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
SN - Senegal 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BZ - Belize 1
EE - Estonia 1
GD - Grenada 1
GI - Gibilterra 1
HR - Croazia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 11.033
Salva come PNG Salva come JPEG
Città #
Chandler 605
Singapore 588
Ashburn 416
Jacksonville 195
San Mateo 187
Beijing 174
Dublin 155
Dearborn 133
Nanjing 111
Munich 102
Jakarta 99
Los Angeles 96
Wilmington 94
Boston 91
Woodbridge 89
Nürnberg 86
Dallas 80
New York 76
Hefei 69
Rome 69
Ann Arbor 61
Milan 61
Lawrence 59
The Dalles 58
Abidjan 55
São Paulo 53
Marseille 52
Izmir 49
Moscow 46
Cattolica 44
Helsinki 44
Redwood City 43
Nanchang 42
Bremen 40
Seattle 40
Houston 39
Fairfield 38
Ho Chi Minh City 38
Boardman 36
Frankfurt am Main 32
Hanoi 30
University Park 30
Princeton 29
Brussels 27
Hyderabad 25
Shenyang 25
Buffalo 23
Fremont 23
Kunming 23
Turku 22
Atlanta 21
Santa Clara 21
Stockholm 21
Tokyo 21
Hong Kong 20
Jiaxing 20
Leawood 20
Mountain View 20
Shanghai 20
Norwalk 19
Rio de Janeiro 19
Brooklyn 18
Guangzhou 18
Zhengzhou 18
Denver 17
Hebei 17
London 17
Auburn Hills 16
Tianjin 15
Baghdad 14
Montreal 14
Warsaw 14
Chennai 13
Detroit 12
Nuremberg 12
Chicago 11
Düsseldorf 11
Hangzhou 11
Kent 11
Phoenix 11
Toronto 11
Vienna 11
Mexico City 10
Orem 10
Redmond 10
San Francisco 10
Seoul 10
Amsterdam 9
Belo Horizonte 9
Changsha 9
Curitiba 9
Mumbai 9
Augusta 8
Bexley 8
Dhaka 8
Johannesburg 8
Paris 8
Poplar 8
Baku 7
Brno 7
Totale 5.373
Salva come PNG Salva come JPEG
Nome #
A National project for in vivo dosimetry procedures in radiotherapy: First results 284
A National project for in vivo dosimetry procedures in radiotherapy: First results 203
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 196
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 182
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 170
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 169
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 165
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 161
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 160
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 157
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 149
In Vivo Portal Dosimetry by an Ionization Chamber 148
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 148
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 145
ASi EPIDs for the in-vivo dosimetry of static and dynamic beams 145
Generalized EPID calibration for in-vivo transit dosimetry A. Fidanzio, S. Cilla, F. Greco, L. Azario, A. Piermattei 140
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 140
aSi-EPID transit signal calibration for dynamic beams: a needful step for the IMRT in vivo dosimetry 140
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 139
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 137
Calibration of portal imaging devices for radiotherapy in-vivo dosimetry A. Piermattei, S.Cilla, A.Fidanzio, F.Greco, L.Azario. 135
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 135
Quasi real time in vivo dosimetry for VMAT 133
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 133
Real time transit dosimetry for the breath-hold radiotherapy technique experience 129
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 128
A generalized calibration procedure for in vivo transit dosimetry using siemens electronic portal imaging devices 126
Correlation functions for Elekta aSi-EPIDs used as transit dosimeter for open fields. S. Cilla, A. Fidanzio, F. Greco, L. Azario, A. Piermattei. 125
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 125
Virtual simulation:fifteen years later 123
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 121
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 121
Calibration of Elekta aSi EPIDs used as transit dosimeter S. Cilla, A. Fidanzio, F. Greco, L. Azario, A. Piermattei. 120
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 119
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 118
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 115
CR-39 detectors based thermal-neutron flux measurements in the phones project 113
A generalized calibration procedure for in vivo transit dosimetry using siemens electronic portal imaging devices 113
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 110
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
Routine EPID in-vivo dosimetry in a reference point for conformal radiotherapy treatments 110
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 108
Step-and-Shoot IMRT by Siemens Beams: An EPID Dosimetry Verification During Treatment 108
Calibration factors for ionization chambers used for reference air kerma rate determination. 107
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 106
Dynamic conformal arc therapy: Transmitted signal in vivo dosimetry 105
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 105
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 102
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 101
Dosimetric calibration of solid state detectors with low energy beta sources 101
Droplet digital PCR for large genomic rearrangements detection: A promising strategy in tissue BRCA1 testing 101
Generalized EPID calibration for in vivo transit dosimetry 100
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 98
DYNAMIC CONFORMAL ARC THERAPY: TRANSMITTED SIGNAL IN-VIVO DOSIMETRY 97
Step-and-Shoot IMRT by Siemens Beams: An EPID Dosimetry Verification During Treatment 97
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 97
A method to determine the planar dose distributions in patients undergone radiotherapy 96
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 95
A validation study of a dedicated software for an automated in vivo dosimetry control in radiotherapy 95
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 93
Breast in vivo dosimetry by EPID 92
Role of Homologous Recombination Repair (HRR) Genes in Uterine Leiomyosarcomas: A Retrospective Analysis 92
Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer 90
Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study 90
What’s beyond BRCA Mutational Status in High Grade Serous Ovarian Cancer? The Impact of Hormone Receptor Expression in a Large BRCA-Profiled Ovarian Cancer Patient Series: A Retrospective Cohort Study 89
Real time transit dosimetry for the breath-hold radiotherapy technique: an initial experience 89
Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study 89
Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study 89
Preliminary results in solid state dosimetry of proton beams for ocular pathology treatment 87
aSi-EPID transit signal calibration for dynamic beams: a needful step for the IMRT in vivo dosimetry 87
Epid cine acquisition mode for in vivo dosimetry in dynamic arc radiation therapy 87
Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis 85
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 84
Dose-guided radiotherapy for lung tumors 83
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase i study. 82
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 82
In patient dose reconstruction using a cine acquisition for dynamic arc radiation therapy 82
Breast in vivo dosimetry by EPID 81
Epid-based in vivo dose verification for lung stereotactic treatments delivered with multiple breath-hold segmented volumetric modulated arc therapy 80
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 79
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 79
A Feasibility Study for in vivo Dosimetry Procedure in Routine Clinical Practice 79
Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer 77
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 75
Adding Ipsilateral V20 and V30 to Conventional Dosimetric Constraints Predicts Radiation Pneumonitis in Stage IIIA-B NSCLC Treated With Combined-Modality Therapy 75
Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior 73
EPID cine acquisition mode for in-vivo dosimetry in dynamic arc radiation therapy 72
integration between in vivo dosimetry and image guided raditherapy for lung tumors 69
Generalized EPID calibration for in-vivo transit dosimetry 68
Intensity Modulated Radiation Therapy (IMRT) with simultaneous integrated boost in unresected left-sided pleural mesothelioma: a case report S. Cilla, A. Piermattei. 67
Beams Arrangement in Non-Small Cell Lung Cancer (NSCLC) According to PTV and Dosimetric Parameters Predictive of Pneumonitis 65
Whole-breast irradiation: A subgroup analysis of criteria to stratify for prone position treatment 59
Origin of residual tumor masses in {BRCA}1/2-driven ovarian carcinomas treated by neoadjuvant chemotherapy: selection of preexisting {BRCA}1/2-proficient tumor cells but not the gain of second {ORF}-restoring mutation 42
Quality handbook in radiotherapy: personal experience 29
Totale 11.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 30 82 18 93 85 112 28
2021/2022768 48 71 11 56 64 22 14 142 23 43 112 162
2022/20231.814 240 259 108 281 90 227 128 157 194 19 96 15
2023/2024833 31 228 18 86 18 88 78 52 14 17 106 97
2024/20251.723 57 40 128 77 157 56 40 71 288 199 330 280
2025/20262.487 710 135 293 442 761 146 0 0 0 0 0 0
Totale 11.100